To evaluate the diagnostic performance of gastric contrast ultrasound (GCUS) in comparison with conventional diagnostic techniques for hiatal hernia (HH), specifically focusing on accuracy and patient experience.
Key Findings:
GCUS provides real-time functional dynamics of HH, which conventional imaging may miss, with potential diagnostic accuracy rates to be included.
GCUS is non-invasive, radiation-free, and well-tolerated by patients, enhancing patient experience.
Interpretation:
GCUS shows promise as a sensitive and specific alternative for diagnosing hiatal hernia, potentially improving patient outcomes and diagnostic accuracy through its unique imaging capabilities.
Limitations:
Single-centre study may limit generalizability.
Retrospective design may introduce selection bias.
Potential biases related to the lack of randomization and control.
Conclusion:
GCUS is a viable, non-invasive diagnostic tool for hiatal hernia assessment, warranting further research to validate its clinical utility and address the limitations identified.
The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.
